These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22119778)

  • 61. Implications of COVID-19 Pandemic on Evolution of Diabetes in Malaria-Endemic African Region.
    Acquah S
    J Diabetes Res; 2020; 2020():8205261. PubMed ID: 33134395
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review.
    Borém LMA; Neto JFR; Brandi IV; Lelis DF; Santos SHS
    Hypertens Res; 2018 Jun; 41(6):394-405. PubMed ID: 29636553
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).
    Santos RAS; Sampaio WO; Alzamora AC; Motta-Santos D; Alenina N; Bader M; Campagnole-Santos MJ
    Physiol Rev; 2018 Jan; 98(1):505-553. PubMed ID: 29351514
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.
    Karnik SS; Singh KD; Tirupula K; Unal H
    Br J Pharmacol; 2017 May; 174(9):737-753. PubMed ID: 28194766
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MAS C-Terminal Tail Interacting Proteins Identified by Mass Spectrometry- Based Proteomic Approach.
    Tirupula KC; Zhang D; Osbourne A; Chatterjee A; Desnoyer R; Willard B; Karnik SS
    PLoS One; 2015; 10(10):e0140872. PubMed ID: 26484771
    [TBL] [Abstract][Full Text] [Related]  

  • 67. International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].
    Karnik SS; Unal H; Kemp JR; Tirupula KC; Eguchi S; Vanderheyden PM; Thomas WG
    Pharmacol Rev; 2015 Oct; 67(4):754-819. PubMed ID: 26315714
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Atypical signaling and functional desensitization response of MAS receptor to peptide ligands.
    Tirupula KC; Desnoyer R; Speth RC; Karnik SS
    PLoS One; 2014; 9(7):e103520. PubMed ID: 25068582
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats.
    Santos SH; Giani JF; Burghi V; Miquet JG; Qadri F; Braga JF; Todiras M; Kotnik K; Alenina N; Dominici FP; Santos RA; Bader M
    J Mol Med (Berl); 2014 Mar; 92(3):255-65. PubMed ID: 24162089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
    Frantz ED; Crespo-Mascarenhas C; Barreto-Vianna AR; Aguila MB; Mandarim-de-Lacerda CA
    PLoS One; 2013; 8(7):e67192. PubMed ID: 23894285
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.
    Marcus Y; Shefer G; Sasson K; Kohen F; Limor R; Pappo O; Nevo N; Biton I; Bach M; Berkutzki T; Fridkin M; Benayahu D; Shechter Y; Stern N
    Diabetes; 2013 Apr; 62(4):1121-30. PubMed ID: 23250359
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetically altered animal models for Mas and angiotensin-(1-7).
    Alenina N; Xu P; Rentzsch B; Patkin EL; Bader M
    Exp Physiol; 2008 May; 93(5):528-37. PubMed ID: 18156169
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison.
    Villela D; Leonhardt J; Patel N; Joseph J; Kirsch S; Hallberg A; Unger T; Bader M; Santos RA; Sumners C; Steckelings UM
    Clin Sci (Lond); 2015 Feb; 128(4):227-34. PubMed ID: 25328009
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes.
    Mario EG; Santos SH; Ferreira AV; Bader M; Santos RA; Botion LM
    Peptides; 2012 Jan; 33(1):174-7. PubMed ID: 22119778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.
    Santos SH; Fernandes LR; Mario EG; Ferreira AV; Pôrto LC; Alvarez-Leite JI; Botion LM; Bader M; Alenina N; Santos RA
    Diabetes; 2008 Feb; 57(2):340-7. PubMed ID: 18025412
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Estrogen therapy attenuates adiposity markers in spontaneously hypertensive rats.
    Abeles Ed; Cordeiro LM; Martins Ade S; Pesquero JL; Reis AM; Andrade SP; Botion LM
    Metabolism; 2012 Aug; 61(8):1100-7. PubMed ID: 22386939
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.